BOULDER, Colo., Sept. 3, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Morgan Stanley 2014 Global Healthcare Conference in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: Morgan Stanley 2014 Global Healthcare Conference Presenter: Ron Squarer, Chief Executive Officer Date: Wednesday, September 10, 2014 Time: 12:55 p.m. Eastern Time Location: Grand Hyatt New York Webcast: www.arraybiopharma.com
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Phase 3 or pivotal studies are already in progress, or are planned to begin this year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520) for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis). For more information on Array, please go to www.arraybiopharma.com.
CONTACT: Tricia Haugeto Array BioPharma Inc. 303-386-1193 firstname.lastname@example.org
SOURCE Array BioPharma